TREATMENT OF SPASTICITY OF THE LOWER EXTREMITIES Russian patent published in 2023 - IPC A61K38/48 G06G1/00 A61P21/00 

Abstract RU 2788039 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology. A remedy is presented for use in determining the dose volume of botulinum neurotoxin administered in the treatment of lower limb spasticity in a subject aged 18 years or younger, where the remedy contains: the first element having the first line of numbers indicating the weight of the subject, and the second line of numbers indicating the dose volume of botulinum neurotoxin to be administered to the subject, where the numbers in the first line, indicating a specific weight, are in longitudinal or radial alignment with the corresponding numbers in the second line indicating a specific dose volume, which should be administered to a subject having this particular weight, where the dose volume corresponds to 5 to 15 units per kilogram of the subject’s total body weight per leg. And also, a second element that overlaps the first one and has a hole or holes that make it possible to view lines on the first element. In this case, the first and second elements are interconnected with each other.

EFFECT: invention makes it possible to use it to effectively determine the dose volume of botulinum neurotoxin administered in the treatment of spasticity of the lower extremities in a subject aged 18 years or younger.

8 cl, 5 dwg, 1 tbl, 9 ex

Similar patents RU2788039C2

Title Year Author Number
THERAPEUTIC AND COSMETIC USE OF SEROTYPE E NEUROTOXIN BOTULINUM 2019
  • Pons, Laurent
RU2800604C2
METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION BY MODIFIED CLOSTRIDIAL TOXIN 2010
  • Gaksiola Gustavo M.
  • Agilar Ivan E.
  • Pas Gil'Berto P.
RU2568844C2
SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER 2019
  • Kalinichev, Mikhail
  • Favre, Christine
RU2791640C2
USE OF BOTULINUM NEUROTOXINS IN TREATMENT 2018
  • Abushakra Sawsan
  • Ahmad Wajdie
  • Hasan Fauad
  • Jarpe Michael
RU2766147C2
COLLECTION OF PHYSIOTHERAPEUTIC INFORMATION TO INCREASE THE EFFICIENCY OF BOTULISM TOXIN TREATMENT 2017
  • Gracies, Jean-Michel
RU2770993C2
THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR MANAGING PAIN INDUSED BY AT LEAST ONE ANTI-CANCER AGENT 2007
  • Favr Kristin
  • Oge Mishel'
  • Shabrie De Lasson'Er P'Er-Eht'Enn
RU2483747C2
LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE 2017
  • Yarstad, Anders
  • Friis, Anna
  • Shtal, Ulf
  • Gurell, Ann
  • Agren, Barbro
  • Edstrom, Emiliya
  • Pikett, Endryu
RU2741497C2
IMPROVED USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA 2018
  • Chikosh, Yanosh
  • Pulte, Irena
  • Altkhaus, Mikhael
  • Kryuer, Markus
  • Vegener, Niko
RU2778481C2
BOTULINUM TOXIN FOR USE IN TREATING PARATONIA 2015
  • Kleiner-Fisman Galit
RU2700939C2
PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING POLOXAMER 2009
  • Khant Terrens Dzh.
RU2482874C2

RU 2 788 039 C2

Authors

Pearl, Donald

Santos, Ayanna

Dates

2023-01-16Published

2018-07-27Filed